Multiple myeloma trials in Denmark

26 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.

• Phase 2Taking people
  Bispecific T-cell Redirectors as Part of First Line Treatment in Transplant Eligible Multiple Myeloma Patients

  Where

  Copenhagen, Odense, Vejle

  Age

  18 years to 70 years

  People

  50 worldwide

  Run by

  North Estonia Medical Centre

  See details and how to joinNCT06505369